Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ESPR

ESPR News

Newswire

09:59

Esperion Therapeutics shares surge 13.75% intraday after Piper Sandler initiates coverage with buy rating, $9 price target.

09:34

Esperion: Piper Sandler initiates Overweight coverage, PT $9.

08:07

Esperion's NEXLETOL Receives National Pricing Approval in Japan, Launches and Receives $90 Million Payment

08:01

Esperion's NEXLETOL Receives National Approval and Launches in Japan for Hypercholesterolemia Treatment

08:03

Esperion to present at Piper Sandler Healthcare Conference on Dec 3.

View More

About ESPR

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More